Loading...
Loading...
EKSO BIONICS HOLDINGS, INC.
EKSO BIONICS HOLDINGS, INC.. Spoken Alpha tracks CHRN's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks CHRN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CHRN.
curl https://api.spokenalpha.com/v1/companies/CHRN| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.31 | $3.69 | -10.2% | +1.6% | +1.7% |
| Q4 FY2026 | $3.26 | $3.59 | -9.3% | +1.5% | +3.6% |
| Q3 FY2026 | $3.04 | $3.66 | -16.9% | +3.7% | +4.7% |
| Q2 FY2026 | $3.38 | $3.86 | -12.5% | +5.6% | +5.5% |
| Q1 FY2025 | $2.94 | $3.72 | -20.9% | -0.2% | -2.2% |
| Q4 FY2025 | $3.36 | $3.95 | -15.0% | +4.0% | +2.9% |
| Q3 FY2025 | $3.24 | $3.72 | -12.9% | +4.9% | +2.7% |
| Q2 FY2025 | $3.58 | $3.81 | -6.0% | +0.8% | -1.2% |
| Q1 FY2024 | $3.76 | $3.99 | -5.7% | +0.6% | -1.3% |
| Q4 FY2024 | $3.36 | $3.82 | -12.1% | +9.0% | +7.5% |